Spironolactone Does Not Improve Psoriasis
Spironolactone is not indicated for the treatment of psoriasis and should not be used for this condition. The FDA-approved indications for spironolactone are limited to heart failure, hypertension, edema associated with hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism 1. There is no evidence supporting its use in psoriasis.
Why This Matters
The evidence provided consists entirely of guidelines and studies focused on:
- Acne treatment in women, where spironolactone has demonstrated efficacy through its anti-androgenic effects on sebaceous glands 2, 3
- Psoriasis management guidelines that discuss appropriate systemic therapies including methotrexate, retinoids, cyclosporine, and biologics 4, 5, 6
Notably, none of the psoriasis guidelines mention spironolactone as a treatment option, which is highly significant given these are comprehensive, recent guidelines from major dermatology organizations.
The Mechanism Doesn't Match
Spironolactone works as an aldosterone receptor antagonist with anti-androgenic properties 1. It reduces sebum production by blocking androgen receptors in sebocytes, which is why it's effective for acne 2.
Psoriasis, however, is a chronic inflammatory skin disease driven by immune dysregulation, not androgen-mediated sebum production 5. The pathophysiology involves T-cell activation and inflammatory cytokines—mechanisms that spironolactone does not address.
What Actually Works for Psoriasis
For moderate-to-severe psoriasis, evidence-based treatments include:
- Biologics (TNF-α inhibitors like etanercept, IL-17 inhibitors, IL-23 inhibitors) 5
- Systemic agents (methotrexate, cyclosporine, acitretin) 4, 6
- Topical therapies for mild disease (calcipotriol/betamethasone combinations) 7
Important Safety Consideration
One research study 8 found that topical spironolactone may actually limit glucocorticoid-induced epidermal atrophy when co-applied with topical steroids. However, this addresses a side effect of steroid treatment, not psoriasis itself, and involves topical rather than systemic administration.
The Bottom Line
If you're considering spironolactone because a patient has both acne and psoriasis, treat these as separate conditions. Use spironolactone for the acne component in appropriate female patients 2, 3, but select evidence-based psoriasis therapies based on disease severity and patient characteristics as outlined in current guidelines 5, 6.